Anna D. Barker, PhD
Chief Strategy Officer, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California

Charles L. Cooney, PhD
Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation

Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE) 

Michael A. Cusumano, PhD
Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management

Hans-Georg Eichler, MD, MSc
Consulting Physician, Association of Austrian Social Insurance Institutions

Elazer Edelman, MD, PhD, FACC
Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT 

Andrew Lo, PhD
Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management

Kenneth A. Oye, PhD
Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology

Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program

Richard Platt, MD, MSc
Executive Director, Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School

Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)

Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University 

Michael S. Sherman, MD, MBA, MS, CPE
Executive Vice President & Chief Medical Officer; Point32Health

Anthony Sinskey, ScD
Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT

Peter Szolovits, PhD
Professor, Department of Electrical Engineering and Computer Science (EECS), Institute for Medical Engineering and Science (IMES), Massachusetts Institute of Technology

Susan Windham-Bannister, PhD
President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC 

Janet Woodcock, MD
Principal Deputy Commissioner, US Food and Drug Administration